Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

Neonatal G6PD

Labsystems Diagnostics' Neonatal G6PD is an enzymatic method for the quantitative determination of glucose-6-phosphate dehydrogenase activity in blood samples dried on filter paper, with fluorometric detection, intended for newborn screening of glucose-6-phosphate dehydrogenase deficiency.

OVERVIEW

NADP+ is reduced by glucose-6-phosphate dehydrogenase enzyme (G-6-PD) in the presence of glucose-6-phosphate, and the rate of formation of NADPH is proportional to the G-6-PD activity, and is determined fluorometrically.

It is an enzymatic method for the quantitative determination of glucose-6-phosphate dehydrogenase activity from dried blood spots, with fluorometric detection.

TECHNICAL SPECIFICATIONS

Neonatal G6PD, 5 solid plates (96) 480 wells  6199 861 

Neonatal G6PD, 10 solid plates (96) 960 wells  6199 860

BENEFITS

Excellent reproducibility

Superior agreement with external quality samples 

Assay time only 30 minutes 

Good stability